Sutton Wealth Advisors’s Novavax NVAX Stock Holding History

Sutton Wealth Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-692	Closed	-$7.11K	–	1302
2022 Q4	$7.11K	Buy	+692	New	+$12.2K	﹤0.01%	1037
2022 Q3	–	Sell	-22	Closed	-$1.13K	–	1697
2022 Q2	$1.13K	Buy	+22	New	+$1.14K	﹤0.01%	1251
2022 Q1	–	Sell	-5	Closed	-$715	–	1686
2021 Q4	$715	Sell	5 -1	-17%	-$172	﹤0.01%	1422
2021 Q3	$1.24K	Buy	+6	New	+$1.32K	﹤0.01%	1225

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sutton Wealth Advisors's NVAX Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Novavax (NVAX) in Q1 2023, closing a stake of 692 shares — an estimated $7.11K sold.

Sutton Wealth Advisors first reported a position in NVAX in Q3 2021 and held it in 4 quarters. The position peaked at $7.11K in Q4 2022. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

Sutton Wealth Advisors reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
Sutton Wealth Advisors sold 692 Novavax shares in Q1 2023, an estimated $7.11K.
Sutton Wealth Advisors first reported a position in Novavax in Q3 2021 and held it in 4 quarters.
Sutton Wealth Advisors's Novavax position peaked at $7.11K in Q4 2022.
222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.